爱滋病 AIDS
1. Cecil Medicine, 23rd Edition, “History,” Saunders, an imprint of Elsevier Inc., 2008, Chap. 412.
2. Cecil Medicine, 23rd Edition, “History,” Saunders, an imprint of Elsevier Inc., 2008, Chap. 413.
3. Cathcart R, “Vitamin C in the treatment of acquired immune deficiency syndrome (AIDS)” Medical Hypotheses 1984 14(4):423-433.
4. Cathcart R, “Letter to the Editor” Lancet 1990 335:235.
5.EverallI, Hudson L, Kerwin R,’ Decreased absolute levels of ascorbic acid and unaltered vasoactive intestinal polypeptide receptor binding in the frontal cortex in acquired immunodeficiency syndrome” Neuroscience Letters 1997 224(2):119-122.
6. Allard J, et al, “Effects of vitamin E and C supplementation on oxidative stress and viral load in HIV infected subjects” AIDS 1998 12(13):1653-1659.
7. Kotler D, “Antioxidant therapy and HIV infection: 1998 [editorial] “The American Journal of Clinical Nutrition 1998 67:7-9.
8. Cathcart R, “Letter to the Editor” Lancet 1990 335:235.
9. Harakeh S, Jariwalla R, ‘Comparative study of the anti-HIV activities of ascorbate and thiol-containing reducing agents in chronically HIV-infected cells” The American Journal of Clinical Nutrition 199154(6 Suppl): 1231S- 1235S.
10. Harakeh S, Jariwalla R, Pauling L, “Suppression of human immunodeficiency virus replication by ascorbate in chronically and acutely infected cells” Proceedings of the National Academy of Sciences of the United States of America (1990) 87(18):7245-7249.
11. Muller R, et al, “Virological and immunological effects of antioxidant treatment in patients with HIV infection” European Journal of Clinical Investigation 2000 30(10):905-914.
12. Tang A, et al, “Dietary micronutrient intake and risk of progression to acquired immunodeficiency syndrome (AIDS) in human immunodeficiency virus type 1(HIV-1)-infected homosexual men “American Journal of Epidemiology 1993 138(11):937-951.
13. Treitinger A, et al, “Decreased antioxidant defense in individuals infected by the human immunodeficiency virus” European Journal of Clinical Investigation 2000 30(5):454-459.
14. Kataoka A, et al, “Intermittent high-dose vitamin C therapy in patients with HTLV-1 associated myelopathy” Journal of Neurology, Neurosurgery, and Psychiatry 1993 56(11):1213-1216.
15. Kataoka A, et al, “Intermittent high-dose vitamin C therapy in patients with HTLV-1-associated myelopathy” [Article in Japanese] Rinsho Shinkeigaku. Clinical Neurology 1993 33(3):282-288.
16. De la Asuncion J, et al, “AZT treatment induces molecular and ultrastructural oxidative damage to muscle mitochondria. Prevention by antioxidant vitamins”. The Journal of Clinical Investigation 1998 102(1):4-9.
普鲁斯病 Brucellosis
1. Cecil Medicine, 23rd Edition, Chap. 331, Saunders, an imprint of Elsevier Inc., 2008.
2. BouraP, et al, “Monocyte locomotion in anergic chronic brucellosis patients: the in vivo effect of ascorbic acid” lmmunopharmacology and lmmunotoxicology 1989 11(1):119-129.
3. Mick E, “Brucellosis and its treatment. Observations preliminary report” Archives of Pediatrics 1955 72:119-125.
感冒 Common Cold
1. Cecil Medicine, 23rd Edition, Chap. 384, Saunders, an imprint of Elsevier Inc., 2008.
2. CarrA, et al, “Vitamin C and the common cold: using identical twins as controls” The Medical Journal of Australia 19812(8):411-412.
3. Cathcart R, “Vitamin C, titrating to bowel tolerance, anascorbemia, and acute induced scurvy” Medical Hypotheses 1981 7(11):1359-1376.
4. Gorton H, Jarvis K, “The effectiveness of vitamin C in preventing and relieving the symptoms of virus-induced respiratory infections” Journal of Manipulative and Physiological Therapeutics 1999. 22(8):530-533.
5. Hemila H, “Does vitamin C alleviate the symptoms of the common cold? – a review of current evidence” Scandinavian Journal of Infectious Disease 1994 26(1):1-6.
6. Hemila H, “Vitamin C, the placebo effect, and the common cold: a case study of how preconceptions influence the analysis of results”Journal of Clinical Epidemiology 199649(10):1079-1084.
7. Murphy B, et al, “Ascorbic acid (vitamin C) and its effects on parainfluenza type Ill virus infection in cotton-topped marmosets” Laboratory Animal Science 1974 24(1):229-232.
白喉 Diphtheria
1. Cecil Medicine, 23rd Edition, Chap. 315, Saunders, an imprint of Elsevier Inc., 2008.
2. Harde E, Philippe M, “Observations sur le pouvoir antigene du melange toxine diphtherique et vitamin C” Compt Rend Acad d Sc 1934 199:738-739.
3. Greenwald C, Harde E, “Vitamin C and diphtheria toxin” Proceedings of the Society for Experimental Biology and Medicine 1935. 32:1157-1160.
4. Jungeblut C, Zwemer R, “Inactivation of diphtheria toxin in vivo and in vitro by crystalline vitamin C (ascorbic acid) “Proceedings of the Society for Experimental Biology and Medicine 1935. 32:1229-1234.
5. King C, Menten M, “Influence of vitamin level on resistance to diphtheria toxin” Journal of Nutrition 1935 10:129-155.
6. Hanzlik P, Terada B, “Protective measures in diphtheria intoxication” Journal of Pharmacology and Experimental Therapeutics 193656:269-277.
7. Klenner F, “The treatment of poliomyelitis and other virus diseases with vitamin C”Southern Medicine & Surgery 1949 Jul 11(7): 209-214.
8. Klenner F, “Observations of the dose and administration of ascorbic acid when employed beyond the range of a vitamin in human pathology” Journal of Applied Nutrition 1971 23(3&4):61-88.
猫狗瘟 Distemper (Cat & Dog)
1. http://en.wikipedia.org/wiki/Canine _distemper
2. Belfield W, “Vitamin C in treatment of canine and feline distemper complex” Veterinary Medicine/Small Animal Clinician 196762(4):345-348.
3. Klenner F, “Significance of high daily intake of ascorbic acid in preventive medicine” Journal of the International Academy of Preventive Medicine 1974 1(1):45-69.
4. Leveque J, “Ascorbic acid in treatment of the canine distemper complex” Veterinary Medicine/Small Animal Clinician 1969 64(11):997-999, 1001.
杆菌性痢疾 Dysentery, Bacillary (Shigellosis)
1. Cecil Medicine, 23rd Edition, “Shigellosis,” Saunders, an imprint of Elsevier Inc., 2008, Chap. 330
2. Online article at: http://en.wikipedia.org/wiki/Shigellosis
3. Klenner F, “The treatment of poliomyelitis and other virus diseases with vitamin C “Southern Medicine & Surgery 1949. Jul 111(7):209-214.
4. Honjo S, Imaizumi K, “Ascorbic acid content of adrenal and liver in cynomolgus monkeys suffering from bacillary dysentery” Japanese Journal of Medical Science & Biology 1967 20(1):97-102.
5. Honjo S, et al, “Shigellosis in cynomolgus monkeys (Macaca irus) VII. Experimental production of dysentery with a relatively small dose of Shigella flexneri 2a in ascorbic acid deficient monkeys” Japanese Journal of Medical Science&Biology 196922(3):149-162.
脑炎 Encephalitis
1. Online article at: http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0002388/
2. Cecil Medicine, 23rd Edition, “Acute Viral Encephalitis,”Saunders, an imprint of Elsevier Inc., 2008, Chap. 439.
3. Klenner F, “The treatment of poliomyelitis and other virus diseases with vitamin C” Southern Medicine & Surgery 1949 Jul 111(7):209-214.
4. Klenner F, “Massive doses of vitamin C and the virus diseases “Southern Medicine & Surgery 1951 Apr 103(4):101-107.
5. Klenner F, “The use of vitamin C as an antibiotic” Journal of Applied Nutrition 1953 6:274-278.
6. Klenner F,”An ‘insidious’virus”Tri-State Medical Journal 1957 Jul pp.10-12.
7. Klenner F, “The clinical evaluation and treatment of a deadly syndrome caused by an insidious virus” Tri-State Medical Journal 1958 Oct pp. 11-15.
8. Klenner F, “Virus encephalitis as a sequela of the pneumonias” Tri-State Medical Journal 1960 Feb pp.7-11.
9. Klenner F, “Observations of the dose and administration of ascorbic acid when employed beyond the range of a vitamin in human pathology” Journal of Applied Nutrition 1971 23(3&4):61-88.
急性病毒性肝炎 Hepatitis, Acute Viral
1. Cecil Medicine, 23rd Edition, “Acute Vital Hepatitis,” Saunders, an imprint of Elsevier Inc., 2008, Chap. 151.
2. Calleja H, Brooks R, “Acute hepatitis treated with high doses of vitamin C” The Ohio State Medical Journal 1960 56:821-823.
3. Cathcart R, “Vitamin C, titrating to bowel tolerance, anascorbemia, and acute induced scurvy” Medical Hypotheses 1981 7(11):1359-1376.
4. Komar V, Vasil’ev V, “The use of water-soluble vitamins in viral hepatitis A” [Article in Russian] Klinicheskaia Meditsina 199270(1):73-75.
5. Morishige F, Murata A, “Vitamin C for prophylaxis of viral hepatitis B in transfused patients” Journal of the International Academy of Preventive Medicine 19785(1):54-58.
6. Baur H, Staub H, “Therapy of hepatitis with ascorbic acid infusions” [Article in German] Schweizerische Medizinische Wochenschrift 1954 84:595-597.
7. Baetgen D, Results of the treatment of epidemic hepatitis in children with high doses of ascorbic acid in the years 1957-1958″ [Article in German] Medizinische Monatschrift 1961 15:30-36.
8. Dalton W, “Massive doses of vitamin C in the treatment of viral diseases” Journal of the Indiana State Medical Association 1962 Aug pp.1151-1154.
9. Orens S, “Hepatitis B – a ten day cure: a personal history” Bulletin Philadelphia City Dental Society 1983 48(6):4-5.
疱疹感染Herpes Infections
1. Online article at: http://www.medicinenet.com/acyclovir/article.htm
2. Cecil Medicine, 23rd Edition, “Herpes Simplex Virus Infections,” Saunders, an imprint of Elsevier Inc., 2008, Chap. 307.
3. Terezhalmy G, Bottomley W, Pelleu G, “The use of water-soluble bioflavonoid- ascorbic acid complex in the treatment of recurrent herpes labialis” Oral Surgery, Oral Medicine, Oral Pathology 197845(1):56-62.
4. White L, et al, “In vitro effect of ascorbic acid on infectivity of herpes viruses and paramyxoviruses”Journal of Clinical Microbiology 198624(4):527-531.
5. Sagripanti J, et al, “Mechanism of copper-mediated inactivation of herpes simplex virus” Antimicrobial Agents and Chemotherapy 1997 41(4):812-817.
6. Hovi T, et al, “Topical treatment of recurrent mucocutaneous herpes with ascorbic acid-containing solution” Antiviral Research 199527(3):263-270.
麻风 Leprosy
1. Online article at: http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0002323/
2. Cecil Medicine, 23rd Edition,”Leprosy,”Saunders, an imprint of ElsevierInc., 2008, Chap. 347.
3. Sinha S, et al, “A study of blood ascorbic acid in leprosy” International Journal of Leprosy and Other Mycobacterial Diseases 1984 52(2):159-162.
4. Bechelli L, “Vitamin C therapy of the lepra reaction” Revista Brasileira de Leprologia (Sao Paulo) 1939 7:251-255.
5. Ferreira D, “Vitamin C in leprosy” Publicacoes Medicas 1950 20:25-28.
6. Gatti C, Gaona R, “Ascorbic acid in the treatment of leprosy” Archiv Schiffeund Tropenhygiene 1939 43:32-33.
7. Hastings R, et al, “Activity of ascorbic acid in inhibiting the multiplication of M. leprae in the mouse foot pad” International Journal of Leprosy and Other Mycobacterial Diseases 1976 44(4):427-430.
瘧疾 Malaria
1. Online article at: http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001646/
2. Lotze H, “Clinical experimental investigations in benign tertian malaria” [Article in German] Arch f Schiffsu Trop-Hyg 1938 42(7):287-305. Also cited in: Tropical Diseases Bulletin 1938 35:733.
3. Bourke G, Coleman R, Rencricca N, “Effect of ascorbic acid on host resistance in virulent rodent malaria” Clinical Research 1980 28(3):642A.
4. Marva E, et al, “Deleterious synergistic effects of ascorbate and copper on the development of Plasmodium falciparum: an in vitro study in normal and in G6PD-deficient erythrocytes” International Journal of Parasitology 1989 19(7):779-785.
5. Marva E, et al, “The effects of ascorbate-induced free radicals on Plasmodium falciparum” Tropical Medicine and Parasitology 1992 43(1):17-23.
6. MohrW, “VitaminC-stoffwechselundmalaria. Malaria and assimilation of vitamin C” [Article in German] Deut Trop Zeitschrift 1941 45(13):404-405. Also citedin: Tropical Diseases Bulletin 194340(1):13-14.
7. Naraqi S, et al, “Quinine blindness” Papua and New Guinea Medical Journal 1992 35(4):308-310.
8. Winter R, et al, “Potentiation of an antimalarial oxidant drug” Antimicrobial Agents and Chemotherapy 199741(7):1449-1454.
麻疹 Measles
1. Online article at: http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0000148/
2. Cecil Medicine, 23rd Edition, “Measles,” Saunders, an imprint of Elsevier Inc., 2008, Chap.390.
3. Joffe M, Sukha N, Rabson A, “Lymphocyte subsets in measles. Depressed helper/inducer subpopulation reversed by in vitro treatment with levamisole and ascorbicacid “The Journal of Clinical Investigation 1983. 72(3):971-980.
4. Klenner F, “Massive doses of vitamin C and the virus diseases”Southern Medicine & Surgery 1951 Apr 103(4):101-107.
5. Klenner F, “The treatment of poliomyelitis and other virus diseases with vitamin C” Southern Medicine & Surgery 1949. Jul111(7):209-214.
6. Paez de la Torre J, “Ascorbic acid in measles” Archives Argentinos de Pediatria 194524:225-227.
单核细胞症 Mononucleosis
1. Online article at: http://www.ncbi.nlm.nih.gov 1pubmedhealthlPMH00016171
2. Cathcart R, “Vitamin C, titrating to bowel tolerance, anascorbemia, and acute induced scurvy” Medical Hypotheses 1981 7(11):1359-1376.
3. Dalton W, “Massive doses of vitamin C in the treatment of viral diseases” Journal of the Indiana State Medical Association 1962. Aug pp.1151-1154.
4. Klenner F, “Observations of the dose and administration of ascorbic acid when employed beyond the range of a vitamin in human pathology” Journal of Applied Nutrition 1971 23(3&4):61-88.
腮腺炎 Mumps
1. Online article at: http://www.ncbi.nlm.nih.govl pubmedhealthlPMH0002524I
2. Klenner F, “The treatment of polio myelitis and other virus diseases with vitamin C” Southern Medicine & Surgery 1949. Jul 111(7):209-214.
百日咳 Pertussis (Whooping Cough)
1. Online article at: http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0002528/
2. Meier K, “Vitamin C treatment of pertussis” Annales de Pediatrie (Paris) 1945 164:50-53.
3. Ormerod M, Unkauf B, “Ascorbic acid (vitamin C) treatment of whooping cough” Canadian Medical Association Journal 1937 37(2):134-136.
4. Omerod M, et al, “A further report on the ascorbic acid treatment of whooping cough” Canadian Medical Association Journal 193737(3):268-272
5. Otani T, “On the vitamin C therapy of pertussis” Klinische Wochenschrift 1936 15(51):1884-1885.
6. Sessa T, “Vitamin C therapy of whooping cough” Riforma Medica 1940 56:38-43.
7. Vermillion E, Stafford G, “A preliminary report on the use of cevitaminic acid in the treatment of whooping cough” Journal of the Kansas Medical Society 1938 39(11):469, 479.
肺炎 Pneumonia
1. Online article at: http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001200/
2. Locke A, et al, “Fitness, sulfanilamide and pneumococcus infection inthe rabbit” Science 1937 86(2227):228-229.
3. Kaiser A, Slavin B, “The incidence of hemolytic streptococci in the tonsils of children as related to the vitamin C content of tonsils and blood” Journal of Pediatrics 1938 13:322-333.
4. Sabin A, “Vitamin C in relation to experimental poliomyelitis with incidental observations on certain manifestations in Macacus rhesus monkeys on a scorbutic diet” Journal of Experimental Medicine 1939 69:507-515.
5. Gander J, Niederberger W, Munchener Medizinische Wochenschrift 1936 83:1386.
6. Vogl A, Munchener Medizinische Wochenschrift 1937. 84:1569.
7. Bonnholtzer E,Deutsches Med Wochenschrift 193726:1001.
8. Hochwald A, Deutsches Med Wochenschrift 1937. 63:182.
9. Gunzel W, Kroehnert G, “Experiences in the treatment of pneumonia with vitamin C” Fortschrifte der Therapie 1937 13:460-463.
10. Sennewald K, Fortschrifte der Therapie 1938 14:139.
11. Szirmai F, “Value of vitamin C in treatment of acute infectious diseases” Deutsches Archive fur Klinische Medizin 1940 85:434-443.
12. Kimbarowski J, Mokrow N, “Colored precipitation reaction of the urine according to Kimbarowski (FARK) as an index of the effect of ascorbic acid during treatment of viral influenza” [Article in German] Das Deutsche Gesundheitswesen 1967 22(51):2413-2418.
13. Slotkin G, Fletcher R, “Ascorbic acid in pulmonary complications following prostatic surgery: a preliminary report” Journal of Urology 1944 52:566-569.
14. Hamdy A, et al, “Effect of vitamin C on lamb pneumonia and mortality” The Cornell Veterinarian 1967 57(1):12-20.
15. Esposito A, “Ascorbate modulates antibacterial mechanisms in experimental pneumococcal pneumonia” The American Review of Respiratory Disease 1986 133(4):643-647.
16. Pitt H, Costrini A, “Vitamin C prophylaxis in marine recruits” Journal of the American Medical Association 1979 241(9):908-911.
17. Dalton W, “Massive doses of vitamin C in the treatment of viral diseases” Journal of the Indiana State Medical Association (1962) Aug pp.1151-1154.
18. Klenner F, “Virus pneumonia and its treatment with vitamin C” Southern Medicine & Surgery 1948 Feb 110(2):36-38,46.
19. Klenner F, “The use of vitamin C as an antibiotic” Journal of Applied Nutrition 1953 6:274-278.
脊髓灰质炎 Polio
1. Online article at: http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0002375/
2. Jungeblut C, “Inactivation of poliomyelitis virus in vitro by crystalline vitamin C (ascorbic acid)’ Journal of Experimental Medicine 1935 62:517-521.
3. Jungeblut C, “Vitamin C therapy and prophylaxis in experimental poliomyelitis” Journal of Experimental Medicine 193765:127-146.
4. Jungeblut C, “A further contribution to vitamin C therapy in experimental poliomyelitis” Journal of Experimental Medicine 1939 70:315-332.
5. Klenner F, “The treatment of poliomyelitis and other virus diseases with vitamin C” Southern Medicine & Surgery 1949 Jul 111(7):209-214.
6. Baur H, “Poliomyelitis therapy with ascorbic acid” [German] Helvetia Medica Acta 1952 19:470-474.
7. Greer E, “Vitamin C in acute poliomyelitis” Medical Times 1955 83(11):1160-1161.
假单胞菌感染Pseudomonas Infections
1. Online article at: http://emedicine.medscape.com/article/970904-overview
2. Online article at: http://emedicine.medscape.com/article/970904-treatment
3. Carlsson S, et al,”Effects of pH, nitrite, and ascorbic acid on nonenzymatic nitric oxide generation and bacterial growth in urine” Nitric Oxide: Biology and
Chemistry 2001 5(6):580-586.
4. Klenner F, “Observations of the dose and administration of ascorbic acid when employed beyond the range of a vitamin in human pathology” Journal of Applied Nutrition 1971 23(3&4):61-88.
5. Nakanishi T, “A report on a clinical experience of which has successfully made several antibiotics-resistant bacteria (MRSA etc.) negative on a bedsore” [Article in Japanese] lgaku Kenkyu. Acta Medica 1992 62(1):31-37.
6. Nakanishi T, “A report on the therapeutical experiences of which have successfully made several antibiotics-resistant bacteria (MRSA etc.) negative on bedsores and respiratory organs” [Article in Japanese] lgaku Kenkyu. Acta Medica 199363(3):95-100.
7. Rawal B, “Bactericidal action of ascorbic acid on Pseudomonas aeruginosa: alteration of cell surface as a possible mechanism” Chemotherapy 1978 24(3):166-171.
8. Rawal B, Charles B, “Inhibition of Pseudomonas aeruginosa by ascorbic acid- sulphamethoxazole-trimethoprim combination”The Southeast Asian Journal of Tropical Medicine and Public Health 19723(2):225-228.
9. Rawal B, McKay G, Blackhall M, “Inhibition of Pseudomonas aeruginosa by ascorbic acid acting singly and in combination with antimicrobials: in-vitro and in-vivo studies” Medical Journal of Australia 1974 1(6):169-174.
狂犬病 Rabies
1. Online article at: http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0002310/
2. Amato, G. “Azionedell’ acido ascorbico sulvirus fisso dell arabbia e sulla tossina tetanica” Giornale di Batteriologia, Virologia et lmmunologia (Torino) 1937 19:843-847.
3. Banic S, “Prevention of rabies by vitamin C” Nature 1975 258(5531):153-154.
带状疱疹 Shingles
1. Online article at: http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001861/
2. Cecil Medicine, 23rd Edition,”Macular, Papular, Vesiculobullos, and Pustular Disease,” Saunders, an imprint of Elsevier Inc., 2008, Chap.465.
3. Dainow I, “Treatment of herpes zoster with vitamin C” Dermatologia 1943 68:197-201.
4. Klenner F, “The treatment of poliomyelitis and other virus diseases with vitamin C” Southern Medicine & Surgery 1949 Jul 111(7):209-214.
5. Klenner F, “The use of vitamin C as an antibiotic” Journal of Applied Nutrition 1953 6:274-278.
6. Klenner F, “Significance of high daily intake of ascorbic acid in preventive medicine” Journal of the International Academy of Preventive Medicine 1974 1(1):45-69.
7. Zureick M, “Treatment of shingles and herpes with vitamin C intravenously” Journal des Praticiens 1950 64:586.
葡萄球菌感染Staph Infections
1. Online article at: http://www.emedicinehealth.com/staphylococcus/article_ em.him
2. Cecil Medicine, 23rd Edition, “Staphylococcal Infections,” Saunders, an imprint of Elsevier Inc., 2008, Chap.310.
3. Andreasen C, Frank D, “The effects of ascorbic acid on in vitro heterophil function” Avian Diseases 199943(4):656-663.
4. Gupta G, Guha B, “The effect of vitamin C and certain other substances on the growth of microorganisms” Annals of Biochemistry and Experimental Medicine 1941 1(1):14-26.
5. Klenner F, “Significance of high daily intake of ascorbic acid in preventive medicine” Journal of the International Academy of Preventive Medicine 1974 1(1):45-69.
6. Kodama T, Kojima T, “Studies of the staphylococcal toxin, toxoid and antitoxin; effect of ascorbic acid on staphylococcal lysins and organisms” Kitasato Archives of Experimental Medicine 1939 16:36-55.
7. Ledermann E, “Vitamin-C deficiency and ulceration of the face” The Lancet 1962 2:1382.
8. Nakanishi T, “A report on a clinical experience of which has successfully made several antibiotics-resistant bacteria (MRSA etc.) negative on a bedsore” [Article in Japanese] lgaku Kenkyu.ActaMedica199262(1):31-37.
9. Nakanishi T, “A report on the therapeutical experiences of which have successfully made several antibiotics-resistant bacteria (MRSA etc.) negative on bedsores and respiratory organs” [Article in Japanese] lgaku Kenkyu. Acta Medica 199363(3):95-100.
10. Nelson J, et al, “Metabolic and immune effects of enteral ascorbic acid after burn trauma” Burns: Journal of the International Society for Burn Injuries 1992 18(2):92-97.
链球菌感染 Strep Infections
1. Article online at: http://www.nlm.nih.gov 1medlineplus/streptococcalinfections. html
2. Cecil Medicine, 23rd Edition, “Streptococcal Infections,” Saunders, an imprint of Elsevier Inc., 2008, Chap.312.
3. Gnarpe H, Michaelsson M, Dreborg S, “The in vitro effect of ascorbic acid on the bacterial growth in urine” Acta Pathologica et Microbiologica Scandinavica 1968 74(1):41-50.
4. Klenner F, “Significance of high daily intake of ascorbic acid in preventive medicine” Journal of the International Academy of Preventive Medicine 1974 1(1):45-69.
5. Witt W, Hubbard G, Fanton J, “Streptococcus pneumoniae arthritis and osteomyelitis with vitamin C deficiency in guinea pigs” Laboratory Animal Science 198838(2):192-194.
6. Devasena T, Lalitha S, Padma K, “Lipid peroxidation, osmotic fragility and antioxidant status in children with acute post-streptococcal glomerulonephritis” Clinica Chimica Acta 2001 308(1-2):155-161.
7. Ruskin S, “Contribution to the study of grippeotitis, myringitis bullosa hemorrhagica, and its relationship to latent scurvy” Laryngoscope 1938 48:327-334.
8. Massell B, et al, “Antirheumatic activity of ascorbic acid in large doses. Preliminary observations on seven patients with rheumatic fever” The New England Journal of Medicine 1950 242(16):614-615.
9. Glazebrook A, Thomson S, “The administration of vitamin C in a large institution and its effect on general health and resistance to infection” Journal of Hygiene 1942 42(1):1-19.
10. McCormick W, “Vitamin C in the prophylaxis and therapy of infectious diseases” Archives of Pediatrics 1951 68(1):1-9.
11. Cathcart R, “Vitamin C, titrating to bowel tolerance, anascorbemia, and acute induced scurvy” Medical Hypotheses 1981 7(11):1359-1376.
12. Coulehan J, et al, “Vitamin C and acute illness in Navajo school children” The New England Journal of Medicine 1976 295(18):973-977.
破伤风 Tetanus
1. Online article at: http://www.ncbi.nlm.nih.govl pubmedhealthlPMH0001640I
2. Cecil Medicine, 23rd Edition, “Clostridial Infections,”Saunders, an imprint of Elsevier Inc., 2008, Chap.319.
3. Jungeblut C, “Inactivation of tetanus toxin by crystalline vitamin C (L-ascorbic acid)”Journal of Immunology 1937 33:203-214.
4. Kligler I, Guggenheim K, Warburg F, “Influence of ascorbic acid on the growth and toxin production of Cl. tetani and on the detoxication of tetanus toxin” Journal of Pathology 1938 46:619-629.
5. Klenner F, “Case history: cure of a 4-year-old child bitten by a mature highland moccasin with vitamin C” Tri-State Medical Journal 1954 Jul.
6. Dey P, “Efficacy of vitamin C in counteracting tetanus toxicity” Die Naturwissenschaften 196653(12):310.
7. Dey P,”Protective action of ascorbic acid & its precursors on the convulsive & lethal actions of strychnine” Indian Journal of Experimental Biology 1967 5(2):110-112.
8. Klenner F, “Case history: cure of a 4-year-old child bitten by a mature highland moccasin with vitamin C” Tri-State Medical Journal 1954 Jul.
9. Jahan K, Ahmad K, Ali M, “Effect of ascorbic acid in the treatment of tetanus” Bangladesh Medical Research Council Bulletin 1984 10(1):24-28.
结核 Tuberculosis
1. Onlinearticleat:http://www.ncbi.nlm.nih.gov 1pubmedhealthlPMH0001141/
2. Steinbach M, Klein S, “Vitamin C in experimental tuberculosis”American Review of Tuberculosis 1941 43:403-414.
3. Albrecht E, “Vitamin C as an adjuvant in the therapy of lung tuberculosis” Medizinische Klinic (Munchen) 1938 34:972-973.
4. BabbarI, “Observations of ascorbic acid. Part XI. Therapeutic effect of ascorbic acid in tuberculosis” The Indian Medical Gazette 194883:409-410.
5. Birkhaug K,”The role of vitamin C in the pathogenesis of tuberculosis in the guinea pig. I. Daily excretion of vitamin C in urine of L-ascorbic acid treated and control tuberculous animals. II. Vitamin C content of suprarenals of L-ascorbic acid treated and control tuberculous animals” Acta Tuberculosea Scandinavica 1938 12:89-104 & Ill. “Quantitative variations in the haemogram of L-ascorbic acid treated and control tuberculous animals” Acta Tuberculosea Scandinavica 1938 12:359-372.
6. Birkhaug K, “IV. Effect of L-ascorbic acid on the tuberculin reaction in tuberculous animals” Acta Tuberculosea Scandinavica 13:45-51.&” V. Degree of tuberculosis in L-ascorbic acid treated and control tuberculosis animals” Acta Tuberculosea Scandinavica 1939 13:52-66.
7. Bogen E, Hawkins L, Bennett E, “Vitamin C treatment of mucous membrane tuberculosis” American Review of Tuberculosis (1941) 44:596-603.
8. Bossevain C, Spillane J, “A note on the effect of synthetic ascorbic acid (vitamin C) on the growth of the tubercle bacillus” American Review of Tuberculosis 193735:661-662.
9. Borsalino G, “Lafragilita capillare nella tubercolosi polmonare ele sue modificazioni per azione della vitamin C” Giomale di Clinica Medica (Bologna) 1937 18:273-294.
10. CharpyJ,”AscorbicacidinverylargedosesaloneorwithvitaminD2in tuberculosis” Bulletin de l’academie Nationale de Medecine (Paris) 1948 132:421-423.
11. Downes J, “An experiment inthe control of tuberculosis among Negroes” The Milbank Memorial Fund Quarterly 195028:127-159.
12. Faulkner J, Taylor F, “Vitamin C and infection” Annals of Internal Medicine 1937 10:1867-1873.
13. Getz H, Long E, Henderson H, “A study of the relation of nutrition to the development of tuberculosis. Influence of ascorbic acid and vitamin A” American Review of Tuberculosis 195164:381-393.
14. Grant A, American Review of Tuberculosis 1930 21:115.
15. Heise F, Martin G, “Ascorbic acid metabolism in tuberculosis” Proceedings of
the Society for Experimental Biology and Medicine 1936 34:642-644.
16. Heise F, Martin G, “Supervitaminosis C in tuberculosis” Proceedings of the Society for Experimental Biology and Medicine 1936 35:337-338.
17. Hemila H, et al, “Vitamin C and other compounds in vitamin C rich food in relation to risk of tuberculosis in male smokers” American Journal of Epidemiology 1999 150(6):632-641.
18. Klenner F, “Significance of high daily intake of ascorbic acid in preventive medicine” Journal of the International Academy of Preventive Medicine 1974 1(1):45-69.
19. Leichtentritt B, Deutsche Medizinische Wochenschrift 192440:672.
20. Mcconkey M, Smith D, “The relation of vitamin C deficiency to intestinal tuberculosis in the guinea pig”Journal of Experimental Medicine 1933 58:503-512.
21. McCormick W, “Vitamin C in the prophylaxis and therapy of infectious diseases” Archives of Pediatrics 1951 68(1):1-9.
22. Myrvik Q, et al, “Studies on the tuberculo inhibitory properties of ascorbic acid derivatives and their possible role in inhibition of tubercle bacilli by urine” American Review of Tuberculosis (1954) 69:406-418.
23. PetterC,”Vitamin C and tuberculosis” The Journal-Lancet (Minneapolis) 1937 57:221-224.
24. Pijoan M, Sedlacek B, “Ascorbic acid in tuberculous Navajo Indians”American Review of Tuberculosis 194348:342-346.
25. Rudra M, Roy S, “Haematological study in pulmonary tuberculosis and the effect upon it of large doses of vitamin C” Tubercle 1946 27:93-94.
26. Steinbach M, Klein S, “Effect of crystalline vitamin C (ascorbic acid) on tolerance to tuberculin” Proceedings of the Society for Experimental Biology and Medicine 1936 35:151-154.
伤寒 Typhoid Fever
1. Online article at: http:l/www.ncbi.nlm.nih.gov/pubmedhealth/PMH0002308/
2. Drummond J, “Recent advances in the treatment of enteric fever” Clinical Proceedings (South Africa) 1943 2:65-93.
3. Farah N, “Enteric fever treated with suprarenal cortex extract and vitamin C intravenously” Lancet 19381:777-779.
4. Foster D, Obineche E, Traub N, “The effect of pyridoxine, folicacid and ascorbic acid therapy on the incidence of sideroblastic anaemia in Zambians with chloramphenicol treated typhoid. A preliminary report” East African Medical Journal 197451(1):20-25.
5. Hill C, Garren H, “The effect of high levels of vitamins on the resistance of chicks to fowl typhoid” Annals of the New York Academy of Sciences 1955 63:186-194.
